Structure

Physi-Chem Properties

Molecular Weight:  694.39
Volume:  694.743
LogP:  2.397
LogD:  2.68
LogS:  -3.436
# Rotatable Bonds:  8
TPSA:  192.44
# H-Bond Aceptor:  12
# H-Bond Donor:  6
# Rings:  6
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.175
Synthetic Accessibility Score:  5.953
Fsp3:  0.892
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.417
MDCK Permeability:  6.55120747978799e-05
Pgp-inhibitor:  0.949
Pgp-substrate:  0.684
Human Intestinal Absorption (HIA):  0.214
20% Bioavailability (F20%):  0.01
30% Bioavailability (F30%):  0.854

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.029
Plasma Protein Binding (PPB):  66.03225708007812%
Volume Distribution (VD):  0.603
Pgp-substrate:  16.228702545166016%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.319
CYP2C19-inhibitor:  0.002
CYP2C19-substrate:  0.73
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.045
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.097
CYP3A4-inhibitor:  0.232
CYP3A4-substrate:  0.147

ADMET: Excretion

Clearance (CL):  1.818
Half-life (T1/2):  0.56

ADMET: Toxicity

hERG Blockers:  0.361
Human Hepatotoxicity (H-HT):  0.402
Drug-inuced Liver Injury (DILI):  0.05
AMES Toxicity:  0.033
Rat Oral Acute Toxicity:  0.102
Maximum Recommended Daily Dose:  0.293
Skin Sensitization:  0.182
Carcinogencity:  0.021
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.864

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC102619

Natural Product ID:  NPC102619
Common Name*:   Acanthosessilioside C
IUPAC Name:   n.a.
Synonyms:   Acanthosessilioside C
Standard InCHIKey:  PJRCJHUXBYLHNU-RWKILBRVSA-N
Standard InCHI:  InChI=1S/C37H58O12/c1-17(2)18-13-23(40)37(32(45)48-31-29(44)28(43)27(42)21(16-38)47-31)12-11-34(5)19(26(18)37)14-20(39)30-35(34,6)10-9-22-33(3,4)49-24(36(22,30)7)15-25(41)46-8/h18-24,26-31,38-40,42-44H,1,9-16H2,2-8H3/t18-,19+,20+,21+,22-,23-,24+,26+,27+,28-,29+,30-,31-,34+,35+,36+,37+/m0/s1
SMILES:  C=C(C)[C@@H]1C[C@@H]([C@@]2(CC[C@]3(C)[C@H](C[C@H]([C@H]4[C@@]3(C)CC[C@H]3C(C)(C)O[C@H](CC(=O)OC)[C@]43C)O)[C@@H]12)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2063158
PubChem CID:   60155053
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001755] Diterpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. Fruits n.a. n.a. PMID[22691179]
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell Line HCT-116 Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT83 Cell Line MCF7 Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT134 Cell Line SK-BR-3 Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT165 Cell Line HeLa Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT65 Cell Line HepG2 Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT373 Cell Line SK-MEL-5 Homo sapiens IC50 < 10000.0 nM PMID[492833]
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 50000.0 nM PMID[492833]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC102619 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9808 High Similarity NPC272242
0.9712 High Similarity NPC106760
0.9528 High Similarity NPC243572
0.9519 High Similarity NPC224414
0.9252 High Similarity NPC11035
0.9182 High Similarity NPC156651
0.9167 High Similarity NPC470543
0.9151 High Similarity NPC88744
0.9083 High Similarity NPC146563
0.9083 High Similarity NPC73986
0.9065 High Similarity NPC91583
0.9065 High Similarity NPC240125
0.9065 High Similarity NPC473844
0.9065 High Similarity NPC51947
0.9038 High Similarity NPC94919
0.9 High Similarity NPC54395
0.8919 High Similarity NPC469823
0.8919 High Similarity NPC469820
0.8919 High Similarity NPC137414
0.8899 High Similarity NPC240734
0.8899 High Similarity NPC1876
0.8899 High Similarity NPC204392
0.8899 High Similarity NPC91838
0.8899 High Similarity NPC275668
0.8889 High Similarity NPC8431
0.8879 High Similarity NPC273962
0.8846 High Similarity NPC108371
0.8807 High Similarity NPC101450
0.8761 High Similarity NPC239293
0.8761 High Similarity NPC469822
0.8727 High Similarity NPC285410
0.8727 High Similarity NPC263827
0.8727 High Similarity NPC274833
0.8727 High Similarity NPC470311
0.8727 High Similarity NPC250481
0.8727 High Similarity NPC471251
0.8718 High Similarity NPC174367
0.8718 High Similarity NPC47113
0.8716 High Similarity NPC471250
0.8704 High Similarity NPC287269
0.8673 High Similarity NPC473304
0.8661 High Similarity NPC477580
0.8661 High Similarity NPC469821
0.8661 High Similarity NPC116024
0.8654 High Similarity NPC253586
0.8649 High Similarity NPC207845
0.8649 High Similarity NPC472719
0.8644 High Similarity NPC471357
0.8644 High Similarity NPC146456
0.8644 High Similarity NPC469757
0.8644 High Similarity NPC117702
0.8636 High Similarity NPC129340
0.8624 High Similarity NPC195708
0.8611 High Similarity NPC285927
0.8611 High Similarity NPC473199
0.8609 High Similarity NPC471406
0.8584 High Similarity NPC88945
0.8571 High Similarity NPC144068
0.8571 High Similarity NPC260665
0.8559 High Similarity NPC31839
0.8558 High Similarity NPC472989
0.8547 High Similarity NPC27363
0.8545 High Similarity NPC477069
0.8545 High Similarity NPC473570
0.8545 High Similarity NPC477070
0.8545 High Similarity NPC265655
0.8545 High Similarity NPC218853
0.8534 High Similarity NPC470478
0.8522 High Similarity NPC477071
0.85 High Similarity NPC469752
0.85 High Similarity NPC469753
0.85 High Similarity NPC471361
0.85 High Similarity NPC197707
0.85 High Similarity NPC471358
0.85 High Similarity NPC219085
0.85 High Similarity NPC70542
0.85 High Similarity NPC17896
0.85 High Similarity NPC471359
0.85 High Similarity NPC86159
0.85 High Similarity NPC469751
0.85 High Similarity NPC10823
0.85 High Similarity NPC89514
0.85 High Similarity NPC6108
0.85 High Similarity NPC180079
0.85 High Similarity NPC471352
0.85 High Similarity NPC251866
0.85 High Similarity NPC9499
0.85 High Similarity NPC469754
0.85 High Similarity NPC284406
0.85 High Similarity NPC471360
0.85 High Similarity NPC469755
0.8496 Intermediate Similarity NPC473882
0.8487 Intermediate Similarity NPC329784
0.8487 Intermediate Similarity NPC240070
0.8482 Intermediate Similarity NPC48249
0.8482 Intermediate Similarity NPC80843
0.8482 Intermediate Similarity NPC1046
0.8482 Intermediate Similarity NPC471245
0.8482 Intermediate Similarity NPC233003
0.8468 Intermediate Similarity NPC27551
0.8468 Intermediate Similarity NPC255655
0.8468 Intermediate Similarity NPC475317
0.8468 Intermediate Similarity NPC114961
0.8468 Intermediate Similarity NPC154856
0.8468 Intermediate Similarity NPC98633
0.8468 Intermediate Similarity NPC52241
0.8468 Intermediate Similarity NPC242611
0.8468 Intermediate Similarity NPC124053
0.8462 Intermediate Similarity NPC215570
0.8462 Intermediate Similarity NPC156789
0.8455 Intermediate Similarity NPC230888
0.8455 Intermediate Similarity NPC473517
0.8455 Intermediate Similarity NPC38217
0.8455 Intermediate Similarity NPC472988
0.8455 Intermediate Similarity NPC258323
0.8455 Intermediate Similarity NPC295389
0.8448 Intermediate Similarity NPC142151
0.8448 Intermediate Similarity NPC470312
0.8448 Intermediate Similarity NPC144644
0.8448 Intermediate Similarity NPC153673
0.8448 Intermediate Similarity NPC108072
0.8448 Intermediate Similarity NPC473645
0.8448 Intermediate Similarity NPC281840
0.8448 Intermediate Similarity NPC37860
0.8448 Intermediate Similarity NPC110385
0.8448 Intermediate Similarity NPC267694
0.8443 Intermediate Similarity NPC469749
0.8443 Intermediate Similarity NPC247190
0.8443 Intermediate Similarity NPC32793
0.8443 Intermediate Similarity NPC116075
0.8443 Intermediate Similarity NPC146857
0.844 Intermediate Similarity NPC165405
0.8435 Intermediate Similarity NPC475632
0.8435 Intermediate Similarity NPC86020
0.8435 Intermediate Similarity NPC232237
0.8435 Intermediate Similarity NPC105800
0.8426 Intermediate Similarity NPC213190
0.8421 Intermediate Similarity NPC472718
0.8421 Intermediate Similarity NPC244127
0.8417 Intermediate Similarity NPC311534
0.8411 Intermediate Similarity NPC31346
0.8411 Intermediate Similarity NPC477172
0.8407 Intermediate Similarity NPC178981
0.8407 Intermediate Similarity NPC238935
0.8407 Intermediate Similarity NPC132668
0.8407 Intermediate Similarity NPC251309
0.8407 Intermediate Similarity NPC471252
0.8407 Intermediate Similarity NPC285086
0.8407 Intermediate Similarity NPC477944
0.8407 Intermediate Similarity NPC475208
0.8403 Intermediate Similarity NPC250556
0.8403 Intermediate Similarity NPC469750
0.8396 Intermediate Similarity NPC157739
0.8393 Intermediate Similarity NPC292196
0.8393 Intermediate Similarity NPC114188
0.8393 Intermediate Similarity NPC473062
0.8393 Intermediate Similarity NPC122339
0.8393 Intermediate Similarity NPC329953
0.8393 Intermediate Similarity NPC270586
0.8393 Intermediate Similarity NPC477073
0.8393 Intermediate Similarity NPC469824
0.839 Intermediate Similarity NPC160084
0.839 Intermediate Similarity NPC256983
0.839 Intermediate Similarity NPC41129
0.8378 Intermediate Similarity NPC57362
0.8378 Intermediate Similarity NPC131903
0.8378 Intermediate Similarity NPC296761
0.8378 Intermediate Similarity NPC154085
0.8378 Intermediate Similarity NPC306746
0.8378 Intermediate Similarity NPC167383
0.8378 Intermediate Similarity NPC51925
0.8378 Intermediate Similarity NPC43976
0.8378 Intermediate Similarity NPC204407
0.8378 Intermediate Similarity NPC125361
0.8378 Intermediate Similarity NPC237503
0.8378 Intermediate Similarity NPC137917
0.8376 Intermediate Similarity NPC293031
0.8376 Intermediate Similarity NPC68767
0.8376 Intermediate Similarity NPC475182
0.8376 Intermediate Similarity NPC275225
0.8376 Intermediate Similarity NPC51099
0.8374 Intermediate Similarity NPC329636
0.8364 Intermediate Similarity NPC470170
0.8364 Intermediate Similarity NPC234160
0.8364 Intermediate Similarity NPC470169
0.8362 Intermediate Similarity NPC207738
0.8349 Intermediate Similarity NPC475521
0.8349 Intermediate Similarity NPC475365
0.8349 Intermediate Similarity NPC85593
0.8349 Intermediate Similarity NPC469827
0.8349 Intermediate Similarity NPC31430
0.8348 Intermediate Similarity NPC93883
0.8348 Intermediate Similarity NPC179429
0.8347 Intermediate Similarity NPC188234
0.8347 Intermediate Similarity NPC477235
0.8347 Intermediate Similarity NPC276838
0.8347 Intermediate Similarity NPC232785
0.8347 Intermediate Similarity NPC329986
0.8347 Intermediate Similarity NPC125077
0.8347 Intermediate Similarity NPC140092

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC102619 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8739 High Similarity NPD8133 Approved
0.85 High Similarity NPD7319 Approved
0.8417 Intermediate Similarity NPD7736 Approved
0.8403 Intermediate Similarity NPD7507 Approved
0.8182 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD8293 Discontinued
0.8136 Intermediate Similarity NPD8377 Approved
0.8136 Intermediate Similarity NPD8294 Approved
0.812 Intermediate Similarity NPD7327 Approved
0.812 Intermediate Similarity NPD7328 Approved
0.8067 Intermediate Similarity NPD8380 Approved
0.8067 Intermediate Similarity NPD8378 Approved
0.8067 Intermediate Similarity NPD8296 Approved
0.8067 Intermediate Similarity NPD8379 Approved
0.8067 Intermediate Similarity NPD8335 Approved
0.8067 Intermediate Similarity NPD8033 Approved
0.8051 Intermediate Similarity NPD7516 Approved
0.8036 Intermediate Similarity NPD6412 Phase 2
0.8 Intermediate Similarity NPD6370 Approved
0.7895 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7869 Intermediate Similarity NPD7492 Approved
0.7833 Intermediate Similarity NPD6059 Approved
0.7833 Intermediate Similarity NPD6054 Approved
0.7805 Intermediate Similarity NPD6616 Approved
0.7787 Intermediate Similarity NPD8328 Phase 3
0.7757 Intermediate Similarity NPD8171 Discontinued
0.7742 Intermediate Similarity NPD7078 Approved
0.7664 Intermediate Similarity NPD8034 Phase 2
0.7664 Intermediate Similarity NPD8035 Phase 2
0.7623 Intermediate Similarity NPD6016 Approved
0.7623 Intermediate Similarity NPD6015 Approved
0.7561 Intermediate Similarity NPD5988 Approved
0.7541 Intermediate Similarity NPD6319 Approved
0.75 Intermediate Similarity NPD6686 Approved
0.748 Intermediate Similarity NPD7503 Approved
0.7429 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7395 Intermediate Similarity NPD6882 Approved
0.7395 Intermediate Similarity NPD8297 Approved
0.7295 Intermediate Similarity NPD6009 Approved
0.7266 Intermediate Similarity NPD6033 Approved
0.7222 Intermediate Similarity NPD6067 Discontinued
0.7203 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD7320 Approved
0.72 Intermediate Similarity NPD8513 Phase 3
0.72 Intermediate Similarity NPD8517 Approved
0.72 Intermediate Similarity NPD8516 Approved
0.72 Intermediate Similarity NPD8515 Approved
0.719 Intermediate Similarity NPD4632 Approved
0.7179 Intermediate Similarity NPD6675 Approved
0.7179 Intermediate Similarity NPD6402 Approved
0.7179 Intermediate Similarity NPD7128 Approved
0.7179 Intermediate Similarity NPD5739 Approved
0.7143 Intermediate Similarity NPD6373 Approved
0.7143 Intermediate Similarity NPD6372 Approved
0.7115 Intermediate Similarity NPD6928 Phase 2
0.7105 Intermediate Similarity NPD7638 Approved
0.7059 Intermediate Similarity NPD6899 Approved
0.7059 Intermediate Similarity NPD6881 Approved
0.7043 Intermediate Similarity NPD7639 Approved
0.7043 Intermediate Similarity NPD7640 Approved
0.7034 Intermediate Similarity NPD6008 Approved
0.7025 Intermediate Similarity NPD6650 Approved
0.7025 Intermediate Similarity NPD6649 Approved
0.7025 Intermediate Similarity NPD8130 Phase 1
0.7016 Intermediate Similarity NPD7115 Discovery
0.6975 Remote Similarity NPD5701 Approved
0.6975 Remote Similarity NPD5697 Approved
0.6942 Remote Similarity NPD7290 Approved
0.6942 Remote Similarity NPD7102 Approved
0.6942 Remote Similarity NPD4634 Approved
0.6942 Remote Similarity NPD6883 Approved
0.6935 Remote Similarity NPD6940 Discontinued
0.6923 Remote Similarity NPD6697 Approved
0.6923 Remote Similarity NPD6118 Approved
0.6923 Remote Similarity NPD6115 Approved
0.6923 Remote Similarity NPD6114 Approved
0.6885 Remote Similarity NPD6869 Approved
0.6885 Remote Similarity NPD6847 Approved
0.6885 Remote Similarity NPD6617 Approved
0.687 Remote Similarity NPD6083 Phase 2
0.687 Remote Similarity NPD6084 Phase 2
0.686 Remote Similarity NPD6012 Approved
0.686 Remote Similarity NPD6014 Approved
0.686 Remote Similarity NPD6013 Approved
0.6827 Remote Similarity NPD6116 Phase 1
0.6822 Remote Similarity NPD7604 Phase 2
0.6814 Remote Similarity NPD6399 Phase 3
0.6797 Remote Similarity NPD5983 Phase 2
0.6777 Remote Similarity NPD6011 Approved
0.6767 Remote Similarity NPD5956 Approved
0.6759 Remote Similarity NPD4788 Approved
0.6754 Remote Similarity NPD7748 Approved
0.6748 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6731 Remote Similarity NPD6117 Approved
0.6724 Remote Similarity NPD7902 Approved
0.6724 Remote Similarity NPD4755 Approved
0.6721 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6718 Remote Similarity NPD6336 Discontinued
0.6696 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6695 Remote Similarity NPD1700 Approved
0.6667 Remote Similarity NPD4202 Approved
0.6667 Remote Similarity NPD4056 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4057 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6921 Approved
0.6639 Remote Similarity NPD7632 Discontinued
0.6613 Remote Similarity NPD8413 Clinical (unspecified phase)
0.661 Remote Similarity NPD5286 Approved
0.661 Remote Similarity NPD4696 Approved
0.661 Remote Similarity NPD5285 Approved
0.661 Remote Similarity NPD4700 Approved
0.6607 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7515 Phase 2
0.6557 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6552 Remote Similarity NPD5695 Phase 3
0.6544 Remote Similarity NPD8449 Approved
0.6541 Remote Similarity NPD8074 Phase 3
0.6538 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6535 Remote Similarity NPD6274 Approved
0.6532 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6528 Remote Similarity NPD7625 Phase 1
0.6525 Remote Similarity NPD4225 Approved
0.6525 Remote Similarity NPD5696 Approved
0.6512 Remote Similarity NPD7101 Approved
0.6512 Remote Similarity NPD7100 Approved
0.65 Remote Similarity NPD5225 Approved
0.65 Remote Similarity NPD5226 Approved
0.65 Remote Similarity NPD5224 Approved
0.65 Remote Similarity NPD4633 Approved
0.65 Remote Similarity NPD5211 Phase 2
0.6496 Remote Similarity NPD8450 Suspended
0.6493 Remote Similarity NPD8337 Approved
0.6493 Remote Similarity NPD8336 Approved
0.6481 Remote Similarity NPD7525 Registered
0.6476 Remote Similarity NPD3702 Approved
0.6475 Remote Similarity NPD4767 Approved
0.6475 Remote Similarity NPD4768 Approved
0.6466 Remote Similarity NPD7900 Approved
0.6466 Remote Similarity NPD7901 Clinical (unspecified phase)
0.646 Remote Similarity NPD6903 Approved
0.6455 Remote Similarity NPD3670 Clinical (unspecified phase)
0.6455 Remote Similarity NPD3669 Approved
0.6446 Remote Similarity NPD5174 Approved
0.6446 Remote Similarity NPD5175 Approved
0.6434 Remote Similarity NPD6335 Approved
0.6429 Remote Similarity NPD6409 Approved
0.6429 Remote Similarity NPD7521 Approved
0.6429 Remote Similarity NPD6684 Approved
0.6429 Remote Similarity NPD5330 Approved
0.6429 Remote Similarity NPD6053 Discontinued
0.6429 Remote Similarity NPD7334 Approved
0.6429 Remote Similarity NPD7146 Approved
0.6423 Remote Similarity NPD8338 Approved
0.6417 Remote Similarity NPD5223 Approved
0.6415 Remote Similarity NPD7799 Discontinued
0.6412 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6412 Remote Similarity NPD6909 Approved
0.6412 Remote Similarity NPD6908 Approved
0.641 Remote Similarity NPD7991 Discontinued
0.6404 Remote Similarity NPD5328 Approved
0.6404 Remote Similarity NPD4753 Phase 2
0.6396 Remote Similarity NPD4786 Approved
0.6393 Remote Similarity NPD5141 Approved
0.6371 Remote Similarity NPD4730 Approved
0.6371 Remote Similarity NPD4729 Approved
0.6357 Remote Similarity NPD6317 Approved
0.6325 Remote Similarity NPD6001 Approved
0.6311 Remote Similarity NPD4754 Approved
0.6308 Remote Similarity NPD6314 Approved
0.6308 Remote Similarity NPD6313 Approved
0.6293 Remote Similarity NPD7637 Suspended
0.6293 Remote Similarity NPD6079 Approved
0.6293 Remote Similarity NPD6411 Approved
0.629 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6283 Remote Similarity NPD6098 Approved
0.6283 Remote Similarity NPD3618 Phase 1
0.6273 Remote Similarity NPD1780 Approved
0.6273 Remote Similarity NPD1779 Approved
0.627 Remote Similarity NPD5251 Approved
0.627 Remote Similarity NPD5250 Approved
0.627 Remote Similarity NPD6371 Approved
0.627 Remote Similarity NPD5247 Approved
0.627 Remote Similarity NPD5248 Approved
0.627 Remote Similarity NPD5249 Phase 3
0.6261 Remote Similarity NPD6673 Approved
0.6261 Remote Similarity NPD6080 Approved
0.6261 Remote Similarity NPD6904 Approved
0.625 Remote Similarity NPD3665 Phase 1
0.625 Remote Similarity NPD3666 Approved
0.625 Remote Similarity NPD3133 Approved
0.624 Remote Similarity NPD5128 Approved
0.6231 Remote Similarity NPD8137 Clinical (unspecified phase)
0.6216 Remote Similarity NPD3667 Approved
0.619 Remote Similarity NPD4808 Clinical (unspecified phase)
0.619 Remote Similarity NPD4809 Clinical (unspecified phase)
0.619 Remote Similarity NPD5777 Approved
0.6174 Remote Similarity NPD5737 Approved
0.6174 Remote Similarity NPD6672 Approved
0.6168 Remote Similarity NPD3703 Phase 2
0.6154 Remote Similarity NPD4267 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data